Pharmaceutical Patents and Economic Inequality

Given large financial inequalities, both globally and in most countries, patented medicines routinely exclude most of the patients who need them ...

Pharmaceutical Patents and Economic Inequality - PMC

As pharmaceutical patents deepen the impact of financial inequality by cutting many patients off from the medicines they need, so greater financial inequality— ...

(PDF) Pharmaceutical Patents and Economic Inequality

PDF | Pharmaceutical patents aggravate economic inequality. Some of this effects is missed by economists because they reduce economic to ...

Pharmaceutical Patents and Economic Inequality - PubMed

Pharmaceutical Patents and Economic Inequality. Health Hum Rights. 2023 Dec;25(2):199-204. Author. Thomas Pogge. Affiliation. 1 Leitner Professor of ...

Inequality, Innovation, and Patents - NYU Law

”15 Pharmaceutical firms, long portrayed as perpetrators ... top income inequality, no such correlation has been found between patenting and other forms of.

The Political Economy of Pharmaceutical Patents - Oxford Academic

The centerpiece of these transformations was the requirement that all countries allow patents on pharmaceutical products. Responses to this global shock varied, ...

Pharmaceutical Pricing and Access Beyond Patent Reform

Instead, the United States rewards pharmaceutical manufacturers by combining intellectual property protections with over $250 billion in ...

Patents, Price Controls and Access to New Drugs

The analysis covers a large sample of 68 countries at all income levels and includes all drug launches over the period 1982-2002. It uses newly compiled ...

How Big Pharma Reaps Profits While Hurting Everyday Americans

Moreover, pharmaceutical companies receive substantial U.S. government assistance in the form of publicly funded basic research and tax breaks, ...

Pharmaceutical Patents, Public Health and the Pandemic

The policy debate around patents is linked to its association with the pharmaceutical sector and its impact on accessibility and affordability ...

Inequality Explained: The trouble with pharmaceutical patents

With drug and prescription medication prices skyrocketing to unprecedented levels in recent months, the issue of unaffordable and inaccessible ...

Abandoning Growth and Increasing Inequality: A Critical Look at ...

Oxfam's second proposal—encouraging governments to permanently waive patents in critical areas of international trade, such as the ...

Patents, Monopoly Power, and the Pricing of Pharmaceuticals in ...

inequality is pervasive, within rich nations and poor. Many low ... Scherer, "Economic Effects of Strengthening Pharmaceutical Patent Protection in Italy,".

Patents and pharmaceutical drugs : understanding the pressures on ...

... pharmaceutical drug companies of industrial countries to meet market competition. For legal and economic reasons, patents are fundamental instruments ...

How Do Patents And Economic Policies Affect Access To Essential ...

This study tests the extent to which pharmaceutical patents in developing countries can thwart access to essential medicines. This can be done by quantify ...

How World Trade Rules Threaten the Health of Poor People

As in other sectors, patents are useful in stimulating investment in pharmaceutical research and development (R&D), but the real debate is about the duration ...

The Market Impacts of Pharmaceutical Product Patents in ...

How Generic Drugs, Patents, and Price Controls Affect Markets | NBER

Looking at drug development from a different angle, in Patents and the Global Diffusion of New Drugs (NBER Working Paper No. 20492), Iain M. Cockburn, Jean O.

Prices, Patents and Access to Drugs: Views on Equity and Efficiency ...

In this paper, we answer this question by presenting where economic research stands today and the main approaches that have been taken on international drug ...

Imperfect intellectual property rights in the pharmaceutical industry

Economics of the pharmaceutical industry. ... The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Manage- ment.